Skip to content

Revolution Medicines

US · RVMD #499 by market cap Listed 2020
200.87 +1.00 +0.50%
Live - 5344 symbols - heartbeat 222s ago · 2026-10-08 08:07
Pre-market 200.44 -0.21%
After-hours 199.81 -0.53%
Overnight 199.95 -0.46%
Market cap
43.05B
P/B
16.52
EPS
-5.95
Reader sentiment Are you bullish or bearish on RVMD?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Rating change
    Morgan Stanley Maintains Revolution Medicines(RVMD.US) With Buy Rating, Maintains Target Price $255
    Market Newswire · 2026/9/11
  • Rating change
    A Quick Look at Today's Ratings for Revolution Medicines(RVMD.US), With a Forecast Between $225 to $320
    Market Newswire · 2026/8/27
  • Rating change
    Morgan Stanley Initiates Revolution Medicines(RVMD.US) With Buy Rating, Announces Target Price $255
    Market Newswire · 2026/9/10
  • RBC Capital Maintains Revolution Medicines(RVMD.US) With Buy Rating, Maintains Target Price $251
    Market Newswire · 2026/9/18
  • Rating change
    Truist Financial Maintains Revolution Medicines(RVMD.US) With Buy Rating
    Market Newswire · 2026/9/3
  • Rating change
    Stifel Maintains Revolution Medicines(RVMD.US) With Buy Rating, Maintains Target Price $230
    Market Newswire · 2026/9/14
  • Rating change
    Analysts' Top Healthcare Picks: Revolution Medicines (RVMD), Fortrea Holdings Inc. (FTRE)
    TipRanks · 2026/9/3
  • Rating change
    Jefferies Maintains Revolution Medicines(RVMD.US) With Buy Rating, Maintains Target Price $270
    Market Newswire · 2026/9/3
  • Rating change
    J.P. Morgan Maintains Revolution Medicines(RVMD.US) With Buy Rating, Maintains Target Price $246
    Market Newswire · 2026/9/2
  • Rating change
    Stifel Maintains Revolution Medicines(RVMD.US) With Buy Rating, Raises Target Price to $230
    Market Newswire · 2026/9/9
  • Rating change
    Needham Maintains Revolution Medicines(RVMD.US) With Buy Rating, Raises Target Price to $275
    Market Newswire · 2026/8/31
  • Rating change
    TD Cowen Maintains Revolution Medicines(RVMD.US) With Buy Rating, Announces Target Price $205.15
    Market Newswire · 2026/8/10
  • Rating change
    Analysts Are Bullish on Top Healthcare Stocks: Revolution Medicines (RVMD), ArriVent BioPharma, Inc. (AVBP)
    TipRanks · 2026/9/15
  • LifeSci Capital Maintains Revolution Medicines(RVMD.US) With Buy Rating, Maintains Target Price $315
    Market Newswire · 2026/9/29
  • BofA Securities Maintains Revolution Medicines(RVMD.US) With Buy Rating, Raises Target Price to $265
    Market Newswire · 2026/9/21
  • Rating change
    UBS Maintains Revolution Medicines(RVMD.US) With Buy Rating, Raises Target Price to $265
    Market Newswire · 2026/8/29
  • Rating change
    A Quick Look at Today's Ratings for Revolution Medicines(RVMD.US), With a Forecast Between $239 to $320
    Market Newswire · 2026/8/28
  • Goldman Sachs Initiates Revolution Medicines(RVMD.US) With Buy Rating, Announces Target Price $267
    Market Newswire · 2026/9/24
  • Rating change
    Truist Financial Maintains Revolution Medicines(RVMD.US) With Buy Rating, Announces Target Price $231
    Market Newswire · 2026/8/11
  • Brookline Capital Initiates Revolution Medicines(RVMD.US) With Buy Rating, Announces Target Price $318
    Market Newswire · 2026/9/28

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 08:07:59 · For reference only, not investment advice and not tailored to your situation.